Archives of Clinical Infectious Diseases

Published by: Kowsar

Hepatitis B Core Antibody Immunoglobulin M in Blood Donors With a History of Hepatitis B Virus Infection

Helia Azimi 1 , 2 and Maryam Vaezjalali 1 , 3 , *
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, IR Iran
3 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: July 01, 2016, 11 (3); e38232
  • Published Online: June 12, 2016
  • Article Type: Research Article
  • Received: April 5, 2016
  • Revised: May 2, 2016
  • Accepted: May 10, 2016
  • DOI: 10.5812/archcid.38232

To Cite: Azimi H, Vaezjalali M. Hepatitis B Core Antibody Immunoglobulin M in Blood Donors With a History of Hepatitis B Virus Infection, Arch Clin Infect Dis. 2016 ; 11(3):e38232. doi: 10.5812/archcid.38232.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Almeida Neto C, Strauss E, Sabino EC, Sucupira MC, Chamone DA. Significance of isolated hepatitis B core antibody in blood donors from Sao Paulo. Rev Inst Med Trop Sao Paulo. 2001; 43(4): 203-8[PubMed]
  • 2. Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion. 1998; 38(1): 56-9[PubMed]
  • 3. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol. 2005; 34 Suppl 1-21[PubMed]
  • 4. Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Hepatitis B core antibody testing in Indian blood donors: A double-edged sword! Asian J Transfus Sci. 2012; 6(1): 10-3[DOI][PubMed]
  • 5. Kumar H, Gupta PK, Jaiprakash M. The role of anti-HBc IgM in screening of blood donors. Med J Armed Forces India. 2007; 63(4): 350-2
  • 6. Banerjee K, Sarin SK, Naik SR, Khandekar P. Polymerase chain reaction based diagnostic assay for identification of hepatitis B virus. Indian J Med Res. 1992; 95: 173-8[PubMed]
  • 7. Niermeijer P, Gips CH. Viral antibodies and the infectivity of serum in hepatitis B. N Engl J Med. 1978; 299(17): 958[DOI][PubMed]
  • 8. Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. J Viral Hepat. 2009; 16(4): 259-64[DOI][PubMed]
  • 9. Vaezjalali M, Rezaee H, Goudarzi H. HBV S Gene Premature Stop Codon in Strains From Middle Eastern Patients. Arch Clin Infect Dis. 2012; 8(1): 3-7
  • 10. Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J. 2011; 8: 513[DOI][PubMed]
  • 11. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006; 28: 112-25[DOI][PubMed]
  • 12. Zali MR. Epidemiology of hepatitis B in the Islamic Republic of Iran. EMRO. 1996; 2(2): 290-8
  • 13. Alavian S, Mostajabi P, Malekzadeh R, Azimi K, Vosoogh H, Sarrafi M, et al. Evaluation of hepatitis B transmission risk factors in Tehran blood donors. Govaresh. 2012; 9(3): 169-75
  • 14. Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, et al. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon. 2013; 13(3)[DOI][PubMed]
  • 15. Muhlbacher A, Zdunek D, Melchior W, Michl U. Is infective blood donation missed without screening for antibody to hepatitis B core antigen and/or hepatitis B virus DNA? Vox Sang. 2001; 81(2): 139[PubMed]
  • 16. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood. 2002; 100(7): 2637-41[DOI][PubMed]
  • 17. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med. 2000; 3(4): 192-201
  • 18. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 19. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion. 2007; 47(1): 74-9[DOI][PubMed]
  • 20. El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, et al. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008; 18(1): 55-61[DOI][PubMed]
  • 21. Antar W, El-Shokry MH, Abd El Hamid WA, Helmy MF. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Transfus Med. 2010; 20(6): 409-13[DOI][PubMed]
  • 22. van Ditzhuijsen TJ, Selten GC, van Loon AM, Wolters G, Matthyssen L, Yap SH. Detection of hepatitis B virus DNA in serum and relation with the IgM class anti-HBc titers in hepatitis B virus infection. J Med Virol. 1985; 15(1): 49-56[PubMed]
  • 23. Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood. 2003; 101(6): 2419-25[DOI][PubMed]
  • 24. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion. 2001; 41(5): 652-8[PubMed]
  • 25. Seo DH, Whang DH, Song EY, Kim HS, Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion. 2011; 51(8): 1840-6[DOI][PubMed]
  • 26. Soldan K, Davison K, Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill. 2005; 10(2): 17-9[PubMed]
  • 27. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003; 43(6): 696-704[PubMed]
  • 28. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, et al. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica. 2007; 92(12): 1664-70[DOI][PubMed]
  • 29. Badrawy H, Bakry R. Anti-HBc and HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen. Am J Mol Biol. 2013; 3: 62-6
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments